Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade GliomaMichael Brada, Siow Ming Lee, David E. Levy et al.|Journal of Clinical Oncology|2010Cited by 248
Prognostic and predictive markers in recurrent high grade glioma; results from the BR12 randomised trialV. Peter Collins, Sally Stenning, Koichi Ichimura et al.|Acta Neuropathologica Communications|2014Cited by 34